Financial Freedom »

Crispr Therapeutics shares owned by Financial Freedom

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Financial Freedom from 13F filings

Historical chart of Financial Freedom investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Financial Freedom consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Financial Freedom

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.8k 100 68.16
2023-12-31 $6.3k 100 62.60
2023-09-30 $4.5k 100 45.39

More positions owned by Financial Freedom

Vanguard Intermediate Term Corporate Bond Etf Int-term Corp (VCIT)
Invesco Qqq Tr Unit Ser 1 Unit Ser 1 (QQQ)
Vanguard World Fd Inf Tech Etf Inf Tech Etf (VGT)
Select Sector Spdr Tr Energy Energy (XLE)
Procter & Gamble Company (PG)
Vanguard World Fd Consum Dis Etf Consum Dis Etf (VCR)
Ishares Core Us Aggregate Bond Etf Core Us Aggbd Et (AGG)
Vanguard World Fd Financials Etf Financials Etf (VFH)
Select Sector Spdr Trust Technology Select Sector Usd Dis Technology (XLK)
Vanguard Mun Bd Fds Tax Exempt Bd Tax Exempt Bd (VTEB)
Health Care Select Sector Spdr Sbi Healthcare (XLV)
Vanguard Small-cap Index Fund Small Cp Etf (VB)
Select Sector Spdr Tr Financial Financial (XLF)
Vanguard World Fd Energy Etf Energy Etf (VDE)
Vanguard Mid-cap Index Fund Mid Cap Etf (VO)

View all positions for Financial Freedom

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
BlackRock
Citadel Advisors
Vanguard Group
NEA Management Company
Susquehanna International
Caption Management
Dimensional Fund Advisors
Bellevue Group
T. Rowe Price Associates
Bank of America Corporation
Voloridge Investment Management
Ikarian Capital

View all funds holding Crispr Therapeutics